What is the correct dosage for amoxicillin (amoxicillin/clavulanic acid) 875/125mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin/Clavulanate 875/125mg Dosing

The correct dose for amoxicillin/clavulanate 875/125mg is one tablet twice daily (every 12 hours), which delivers a total daily dose of 1750mg amoxicillin and 250mg clavulanate. 1

Standard Adult Dosing

  • One 875/125mg tablet every 12 hours is the FDA-approved regimen for more severe infections and respiratory tract infections 1
  • This formulation is specifically designed for twice-daily dosing and should not be substituted with other strengths 1
  • The 875/125mg dose is recommended by the Infectious Diseases Society of America specifically for respiratory infections including acute bacterial rhinosinusitis, community-acquired pneumonia, and acute exacerbations of chronic bronchitis 2

Clinical Context and Rationale

  • The 875/125mg twice-daily regimen provides adequate time above the minimum inhibitory concentration (T>MIC) for most common respiratory pathogens 3
  • This dose achieves approximately 4g/day of amoxicillin, which meets the "high-dose" threshold defined in treatment guidelines for overcoming penicillin-resistant Streptococcus pneumoniae 3
  • The formulation maintains coverage against beta-lactamase-producing organisms (H. influenzae, M. catarrhalis) through the clavulanate component 3

Treatment Duration

  • For uncomplicated acute bacterial rhinosinusitis: 5-7 days 2
  • For chronic rhinosinusitis or acute exacerbations: 14 days 3
  • Duration should be based on the specific infection type and clinical response 2

Administration Guidelines

  • Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal side effects 1
  • May be taken without regard to meals, but meal-time administration is preferred for tolerability 1

Critical Dosing Warnings

  • Never substitute two 250/125mg tablets for one 500/125mg tablet - this results in excessive clavulanate dosing (250mg vs 125mg) 2, 1
  • Do not substitute two 500/125mg tablets for one 875/125mg tablet - the clavulanate content differs and this is not an equivalent substitution 1
  • Patients weighing ≥40kg should follow adult dosing recommendations 1

Renal Dosing Adjustments

  • No dose adjustment needed unless glomerular filtration rate (GFR) <30 mL/min 1
  • GFR <30 mL/min: Do not use the 875/125mg formulation - switch to 500/125mg or 250/125mg formulations 1
  • GFR 10-30 mL/min: Use 500/125mg or 250/125mg every 12 hours 1
  • GFR <10 mL/min or hemodialysis: Use 500/125mg or 250/125mg every 24 hours, with additional dose during and after dialysis 1

Evidence for Efficacy

  • The 875/125mg twice-daily regimen demonstrated clinical success rates of 91-93% in acute exacerbations of chronic bronchitis 4
  • This formulation showed 92.3% efficacy against S. pneumoniae in community-acquired pneumonia, including penicillin-resistant strains 5
  • Studies comparing 875/125mg twice daily versus 500/125mg three times daily showed comparable clinical outcomes in chronic rhinosinusitis 3

Common Pitfalls to Avoid

  • Diarrhea is the most common adverse effect - taking with food reduces this risk 3, 1
  • Hepatic monitoring should be performed in patients with hepatic impairment 1
  • The 875/125mg formulation should not be used in pediatric patients <40kg 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.